The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance
B.J. Potter van Loon, C. Kluft, J.K. Radder, M.A. Blankenstein, A.E. MeindersVolume:
42
Year:
1993
Language:
english
Pages:
950
DOI:
10.1016/0026-0495(93)90005-9
File:
PDF, 543 KB
english, 1993